Antipodes discloses 4.8% Brookdale (NYSE: BKD) ownership

Rhea-AI Filing Summary

Antipodes Partners Ltd, an Australian investment adviser, reported beneficial ownership of Brookdale Senior Living Inc. common stock. It holds 11,428,834 shares, representing 4.8% of the outstanding common stock as of the event date of 12/31/2025.

Antipodes has sole power to vote and dispose of all these shares, with no shared voting or dispositive power. The position is certified as being acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Brookdale. The amended Schedule 13G is signed by Managing Director Andrew Findlay.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Brookdale Senior Living Inc.

(Name of Issuer)

Common Stock, $0.01 Par Value Per Share

(Title of Class of Securities)

112463104

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 112463104

1

Names of Reporting Persons

ANTIPODES PARTNERS Ltd

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

AUSTRALIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 11,428,834.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 11,428,834.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

11,428,834.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.8 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Brookdale Senior Living Inc.
(b)	Address of issuer's principal executive offices: 105 WESTWOOD PLACE, 105 WESTWOOD PLACE, BRENTWOOD, TENNESSEE, 37027.
Item 2.
(a)	Name of person filing: ANTIPODES PARTNERS Ltd
(b)	Address or principal business office or, if none, residence: LEVEL 25, AUSTRALIA SQUARE TOWER, 264 GEORGE STREET, SYDNEY, AUSTRALIA, NSW 2000
(c)	Citizenship: AUSTRALIA
(d)	Title of class of securities: Common Stock, $0.01 Par Value Per Share
(e)	CUSIP No.: 112463104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 11,428,834
(b)	Percent of class: 4.8%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 11,428,834
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 11,428,834
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

ANTIPODES PARTNERS Ltd

Signature:	Andrew Findlay
Name/Title:	Managing Director
Date:	01/20/2026

FAQ

What ownership stake in Brookdale Senior Living Inc. (BKD) does Antipodes Partners report?

Antipodes Partners Ltd reports beneficial ownership of 11,428,834 shares of Brookdale Senior Living Inc. common stock, representing 4.8% of the class as of 12/31/2025.

What type of investor is Antipodes Partners in relation to Brookdale (BKD)?

Antipodes Partners Ltd is classified as an investment adviser (IA) and files as a reporting person holding Brookdale Senior Living Inc. common stock.

Does Antipodes Partners control how Brookdale (BKD) shares are voted and disposed?

Yes. Antipodes Partners Ltd reports sole voting power and sole dispositive power over all 11,428,834 Brookdale shares, with no shared power reported.

Is Antipodes Partners seeking to influence control of Brookdale Senior Living Inc.?

No. Antipodes certifies the shares were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Brookdale.

Why is this disclosure for Brookdale (BKD) labeled as Amendment No. 1 to Schedule 13G?

The document is marked as Amendment No. 1 to Schedule 13G, indicating an update to a prior beneficial ownership report for Brookdale by Antipodes Partners Ltd.

Who signed the Brookdale (BKD) Schedule 13G/A on behalf of Antipodes Partners?

The Schedule 13G/A was signed by Andrew Findlay, Managing Director of Antipodes Partners Ltd, dated 01/20/2026.